Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance

by | May 13, 2026 | Clinical Trials | 0 comments

​ Conditions: AL Amyloidosis

Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia

Completed Conditions: AL Amyloidosis
Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *